Home » Topics » BioWorld Science

BioWorld Science
RSS

Selectin inhibitor effective in animal model of early- and late-phase airways inflammation

May 16, 1997

Preclinical studies demonstrate antiinflammatory effects of selective PDE IV inhibitor

May 16, 1997

ABT-080 effective in animal model of lung eosinophilia

May 16, 1997

In vitro characterization of novel CysLTD1 receptor antagonist

May 16, 1997

Endothelin receptor blockade for airways inflammation

May 16, 1997

Airways-selective inhaled steroid for the treatment of asthma

May 16, 1997

Antiproliferative effects of PCA-4230 in vascular smooth muscle cells

May 16, 1997

Company Profile: NitroMed

May 16, 1997

Mouse model for idiopathic voiding disorders in humans

May 15, 1997

BMS and RTI form anticancer alliance

May 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...